Citizens Financial Group Inc Biogen Inc. Transaction History

Citizens Financial Group Inc

$4.91 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$190.52 - $236.72 $196,807 - $244,531	1,033 New	1,033 $239,000
Q2 2022 Aug 05, 2022	SELL	$187.54 - $223.02 $177,412 - $210,976	-946 Reduced 48.24%	1,015 $207,000
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $298,018 - $375,487	-1,538 Reduced 43.96%	1,961 $413,000
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $6.19 Million - $7.96 Million	-27,652 Reduced 88.77%	3,499 $819,000
Q3 2021 Nov 05, 2021	BUY	$282.99 - $369.05 $519,003 - $676,837	1,834 Added 6.26%	31,151 $8.82 Million
Q2 2021 Aug 04, 2021	SELL	$259.0 - $414.71 $101,010 - $161,736	-390 Reduced 1.31%	29,317 $10.2 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $23,566 - $27,609	-97 Reduced 0.33%	29,707 $8.31 Million
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $164,200 - $247,162	-695 Reduced 2.28%	29,804 $7.3 Million
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $239,352 - $276,361	904 Added 3.05%	30,499 $8.64 Million
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $131,916 - $174,700	-510 Reduced 1.69%	29,595 $7.92 Million
Q1 2020 May 08, 2020	SELL	$268.85 - $341.04 $432,310 - $548,392	-1,608 Reduced 5.07%	30,105 $9.53 Million
Q4 2019 Feb 07, 2020	BUY	$220.06 - $304.07 $2.01 Million - $2.78 Million	9,154 Added 40.58%	31,713 $9.41 Million
Q3 2019 Nov 01, 2019	SELL	$217.44 - $243.88 $94,586 - $106,087	-435 Reduced 1.89%	22,559 $5.25 Million
Q2 2019 Aug 09, 2019	SELL	$219.29 - $241.72 $179,379 - $197,726	-818 Reduced 3.44%	22,994 $5.38 Million
Q1 2019 May 09, 2019	BUY	$216.71 - $338.96 $140,428 - $219,646	648 Added 2.8%	23,812 $5.63 Million
Q4 2018 Feb 11, 2019	BUY	$278.5 - $352.75 $11,975 - $15,168	43 Added 0.19%	23,164 $6.97 Million
Q3 2018 Nov 02, 2018	SELL	$293.51 - $383.83 $48,722 - $63,715	-166 Reduced 0.71%	23,121 $8.17 Million
Q2 2018 Jul 27, 2018	BUY	$257.52 - $306.91 $5.9 Million - $7.04 Million	22,928 Added 6386.63%	23,287 $6.76 Million
Q1 2018 May 11, 2018	BUY	$260.13 - $367.91 $33,296 - $47,092	128 Added 55.41%	359 $98,000
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $64,945 - $76,158	231	231 $72,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.49 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.43 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.17 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.09 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$765 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Financial Group Inc with notifications on news.

Account